The role of natriuretic peptides for the diagnosis of left ventricular dysfunction

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Palazzuoli, Alberto ^a   Beltrami, Matteo ^a   Ruocco, Gaetano ^a   Pellegrini, Marco ^a   Nuti, Ranuccio ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NATRIURETIC FACTOR; VALSARTAN; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; CARDIOMEGALY; CARDIOVASCULAR MORTALITY; DIAGNOSTIC ACCURACY; DIASTOLIC DYSFUNCTION; DYSPNEA; ECHOCARDIOGRAPHY; HEART AFTERLOAD; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PERFORMANCE; HEART PRELOAD; HEART RATE VARIABILITY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FILLING; HEART VENTRICLE PRESSURE; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG PRESSURE; MITRAL VALVE REGURGITATION; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PULMONARY ARTERY OCCLUSION PRESSURE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE; TISSUE DOPPLER IMAGING; VASCULAR RESISTANCE; WALL STRESS; ARTIFACT; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL (TOPIC); COMORBIDITY; DIASTOLE; EMERGENCY HEALTH SERVICE; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; PATHOPHYSIOLOGY; RISK ASSESSMENT; STANDARD;

ARTIFACTS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; COMORBIDITY; DIASTOLE; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; HEART FAILURE; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; KIDNEY FAILURE, CHRONIC; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; PEPTIDE FRAGMENTS; REFERENCE STANDARDS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84885672681     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/784670     Document Type: Review

References (64)

1. Gheorghiade M., Pang P. S., Acute heart failure syndromes. Journal of the American College of Cardiology 2009 53 7 557 573 2-s2.0-59749099461 10.1016/j.jacc.2008.10.041
2. McMurray J. J., Adamopoulos S., Anker S. D., Auricchio A., Böhm M., Dickstein K., Falk V., Filippatos G., Fonseca C., Gomez-Sanchez M. A., Jaarsma T., Køber L., Lip G. Y., Maggioni A. P., Parkhomenko A., Pieske B. M., Popescu B. A., Rønnevik P. K., Rutten F. H., Schwitter J., Seferovic P., Stepinska J., Trindade P. T., Voors A. A., Zannad F., Zeiher A., ESC Committee for Practice Guidelines, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. European Heart Journal 2012 33 14 1787 1847 10.1093/eurheartj/ehs104
3. Floras J. S., Sympathetic nervous system activation in human heart failure. Clinical implications of an updated model. Journal of the American College of Cardiology 2009 54 5 375 385 2-s2.0-67650531390 10.1016/j.jacc.2009. 03.061
4. Emdin M., Vittorini S., Passino C., Clerico A., Old and new biomarkers of heart failure. European Journal of Heart Failure 2009 11 4 331 335 2-s2.0-66249144415 10.1093/eurjhf/hfp035
5. Morrow D. A., de Lemos J. A., Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 2007 115 8 949 952 2-s2.0-33847327365 10.1161/CIRCULATIONAHA.106.683110 (Pubitemid 46328287)
6. Vasan R. S., Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006 113 19 2335 2362 2-s2.0-33745004785 10.1161/CIRCULATIONAHA.104.482570 (Pubitemid 43947980)
7. Braunwald E., Medical progress: biomarkers in heart failure. The New England Journal of Medicine 2008 358 20 2094 2159 2-s2.0-43549099569 10.1056/NEJMra0800239 (Pubitemid 351679601)
8. Felker G. M., Adams K. F. Jr., Konstam M. A., O'Connor C. M., Gheorghiade M., The problem of decompensated heart failure: nomenclature, classification, and risk stratification. The American Heart Journal 2003 145 2 S18 S25 2-s2.0-0037323582 10.1067/mhj.2003.150 (Pubitemid 36207921)
9. Gheorghiade M., Zannad F., Sopko G., Klein L., Piña I. L., Konstam M. A., Massie B. M., Roland E., Targum S., Collins S. P., Filippatos G., Tavazzi L., Acute heart failure syndromes: current state and framework for future research. Circulation 2005 112 25 3958 3968 2-s2.0-33644878033 10.1161/CIRCULATIONAHA.105.590091 (Pubitemid 43739494)
10. Palazzuoli A., Nuti R., Heart failure: pathophysiology and clinical picture. Contributions to Nephrology 2010 164 1 10 2-s2.0-77955479938 10.1159/000313714
11. Zile M. R., Baicu C. F., Gaasch W. H., Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. The New England Journal of Medicine 2004 350 19 1953 1959 2-s2.0-3843094224 10.1056/NEJMoa032566 (Pubitemid 38580198)
12. Shammas R. L., Khan N. U. A., Nekkanti R., Movahed A., Diastolic heart failure and left ventricular diastolic dysfunction: what we know, and what we don't know! International Journal of Cardiology 2007 115 3 284 292 2-s2.0-33846849274 10.1016/j.ijcard.2006.03.027 (Pubitemid 46201713)
13. Packer M., The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. Journal of the American College of Cardiology 1992 20 1 248 254 2-s2.0-0026695294
14. Metra M., Cas L. D., Bristow M. R., The pathophysiology of acute heart failure-It is a lot about fluid accumulation. The American Heart Journal 2008 155 1 1 5 2-s2.0-36849050906 10.1016/j.ahj.2007.10.011 (Pubitemid 350234786)
15. Meyer B., Huelsmann M., Wexberg P., Karth G. D., Berger R., Moertl D., Szekeres T., Pacher R., Heinz G., N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Critical Care Medicine 2007 35 10 2268 2273 2-s2.0-34748831708 10.1097/01.CCM.0000284509.23439.5B (Pubitemid 47476222)
16. Maisel A., Hollander J. E., Guss D., McCullough P., Nowak R., Green G., Saltzberg M., Ellison S. R., Bhalla M. A., Bhalla V., Clopton P., Jesse R., Primary results of the rapid emergency department heart failure outpatient trial (REDHOT): a multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. Journal of the American College of Cardiology 2004 44 6 1328 1333 2-s2.0-4444286804 10.1016/j.jacc.2004.06.015
17. Luchner A., Möckel M., Spanuth E., Möcks J., Peetz D., Baum H., Spes C., Wrede C. E., Vollert J., Müller R., Katus H., Giannitsis E., N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial. European Journal of Heart Failure 2012 14 3 259 267 2-s2.0-84857560649 10.1093/eurjhf/hfr171
18. Bettencourt P., Azevedo A., Pimenta J., Friões F., Ferreira S., Ferreira A., N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004 110 15 2168 2174 2-s2.0-5644268954 10.1161/01.CIR.0000144310.04433.BE (Pubitemid 39372496)
19. Masson S., Latini R., Anand I. S., Vago T., Angelici L., Barlera S., Missov E. D., Clerico A., Tognoni G., Cohn J. N., Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the valsartan heart failure (Val-HeFT) data. Clinical Chemistry 2006 52 8 1528 1538 2-s2.0-33746595717 10.1373/clinchem.2006.069575 (Pubitemid 44148316)
20. Troughton R. W., Prior D. L., Pereira J. J., Martin M., Fogarty A., Morehead A., Yandle T. G., Richards A. M., Starling R. C., Young J. B., Thomas J. D., Klein A. L., Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. Journal of the American College of Cardiology 2004 43 3 416 422 2-s2.0-10744229468 10.1016/j.jacc.2003.08.046 (Pubitemid 38167702)
21. Troughton R. W., Richards A. M., B-type natriuretic peptides and echocardiographic measures of cardiac structure and function. JACC: Cardiovascular Imaging 2009 2 2 216 225 2-s2.0-59649110510 10.1016/j.jcmg.2008. 12.006
22. Bistola V., Parissis J. T., Paraskevaidis I., Panou F., Nikolaou M., Ikonomidis I., Flessas N., Filippatos G., Iliodromitis E., Kremastinos D. T., Prognostic value of tissue doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. The American Journal of Cardiology 2010 105 2 249 254 2-s2.0-73149120543 10.1016/j.amjcard.2009.08.682
23. Jourdain P., Jondeau G., Funck F., Gueffet P., Le Helloco A., Donal E., Aupetit J. F., Aumont M. C., Galinier M., Eicher J. C., Cohen-Solal A., Juillière Y., Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. The STARS-BNP multicenter study. Journal of the American College of Cardiology 2007 49 16 1733 1739 2-s2.0-34247135389 10.1016/j.jacc.2006.10.081 (Pubitemid 46589928)
24. Cohen-Solal A., Logeart D., Huang B., Cai D., Nieminen M. S., Mebazaa A., Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. Journal of the American College of Cardiology 2009 53 25 2343 2348 2-s2.0-66949167671 10.1016/j.jacc.2009.02.058
25. Richards A. M., Doughty R., Nicholls M. G., MacMahon S., Sharpe N., Murphy J., Espiner E. A., Frampton C., Yandle T. G., Australia-New Zealand Heart Failure Group, Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Journal of the American College of Cardiology 2001 37 7 1781 1787 2-s2.0-0035369468 10.1016/S0735-1097(01)01269- 4 (Pubitemid 32499959)
26. Fang J., Mensah G. A., Croft J. B., Keenan N. L., Heart Failure-Related Hospitalization in the U.S., 1979 to 2004. Journal of the American College of Cardiology 2008 52 6 428 434 2-s2.0-47849125899 10.1016/j.jacc.2008.03.061 (Pubitemid 352040814)
27. Lam L. L., Cameron P. A., Schneider H. G., Abramson M. J., Müller C., Krum H., Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting. Annals of Internal Medicine 2010 153 11 728 735 2-s2.0-78751694682
28. Silver M. A., Maisel A., Yancy C. W., McCullough P. A., Burnett J. C. Jr., Francis G. S., Mehra M. R., Peacock W. F. IV, Fonarow G., Gibler W. B., Morrow D. A., Hollander J., BNP consensus panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congestive Heart Failure 2004 10 5, supplement 3 1 30 2-s2.0-12144262560
29. Aspromonte N., Valle R., Peacock W. F., Vanderheyden M., Maisel A., Inpatient monitoring and prognostic importance of B-type natriuretic peptide. Congestive Heart Failure 2008 14 4 30 34 2-s2.0-55249090694
30. Maisel A. S., Koon J., Krishnaswamy P., Kazenegra R., Clopton P., Gardetto N., Morrisey R., Garcia A., Chiu A., De Maria A., Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. The American Heart Journal 2001 141 3 367 374 2-s2.0-0035091745 10.1067/mhj.2001. 113215 (Pubitemid 32200264)
31. Heidenreich P. A., Gubens M. A., Fonarow G. C., Konstam M. A., Stevenson L. W., Shekelle P. G., Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. Journal of the American College of Cardiology 2004 43 6 1019 1026 2-s2.0-1542498927 10.1016/j.jacc.2003.10.043 (Pubitemid 38352983)
32. Maeda K., Tsutamoto T., Wada A., Hisanaga T., Kinoshita M., Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. The American Heart Journal 1998 135 5 825 832 2-s2.0-0031862908 10.1016/S0002-8703(98)70041-9 (Pubitemid 28237306)
33. Iwanaga Y., Nishi I., Furuichi S., Noguchi T., Sase K., Kihara Y., Goto Y., Nonogi H., B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. Journal of the American College of Cardiology 2006 47 4 742 748 2-s2.0-32644436929 10.1016/j.jacc.2005.11.030 (Pubitemid 43243094)
34. Goonewardena S. N., Blair J. E. A., Manuchehry A., Brennan J. M., Keller M., Reeves R., Price A., Spencer K. T., Puthumana J., Gheorghiade M., Use of hand carried ultrasound, B-type natriuretic peptide, and clinical assessment in identifying abnormal left ventricular filling pressures in patients referred for right heart catheterization. Journal of Cardiac Failure 2010 16 1 69 75 2-s2.0-72749125149 10.1016/j.cardfail.2009.08.004
35. Dini F. L., Rosa G. M., Fontanive P., Santonato V., Napoli A. M., Ciuti M., Di Bello V., Combining blood flow and tissue Doppler imaging with N-terminal pro-type B natriuretic peptide for risk stratification of clinically stable patients with systolic heart failure. European Journal of Echocardiography 2010 11 4 333 340 2-s2.0-77952001424 10.1093/ejechocard/jep207
36. Vinereanu D., Lim P. O., Frenneaux M. P., Fraser A. G., Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure-a comparison with brain natriuretic peptide. European Journal of Heart Failure 2005 7 4 512 519 2-s2.0-19544366553 10.1016/j.ejheart.2004.07.014 (Pubitemid 40732980)
37. Paulus W. J., Tschöpe C., Sanderson J. E., Rusconi C., Flachskampf F. A., Rademakers F. E., Marino P., Smiseth O. A., de Keulenaer G., Leite-Moreira A. F., Borbély A., Édes I., Handoko M. L., Heymans S., Pezzali N., Pieske B., Dickstein K., Fraser A. G., Brutsaert D. L., How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the european society of cardiology. European Heart Journal 2007 28 20 2539 2550 2-s2.0-34548525319 10.1093/eurheartj/ehm037 (Pubitemid 47614269)
38. Oh J. K., Hatle L., Tajik A. J., Little W. C., Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. Journal of the American College of Cardiology 2006 47 3 500 506 2-s2.0-31644444316 10.1016/j.jacc.2005.09.032 (Pubitemid 43170836)
39. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., Gardetto N., Wanner E., Maisel A. S., Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002 105 5 595 601 2-s2.0-0037022231 10.1161/hc0502.103010 (Pubitemid 34123434)
40. Maeder M. T., Kaye D. M., Heart failure with normal left ventricular ejection fraction. Journal of the American College of Cardiology 2009 53 11 905 918 2-s2.0-61549090009 10.1016/j.jacc.2008.12.007
41. Grewal J., McKelvie R., Lonn E., Tait P., Carlsson J., Gianni M., Jarnert C., Persson H., BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. European Journal of Heart Failure 2008 10 3 252 259 2-s2.0-40449114533 10.1016/j.ejheart.2008.01.017 (Pubitemid 351343862)
42. Tschöpe C., Kašner M., Westermann D., Gaub R., Poller W. C., Schultheiss H. P., The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. European Heart Journal 2005 26 21 2277 2284 2-s2.0-27544455785 10.1093/eurheartj/ehi406 (Pubitemid 41541392)
43. Lim T. K., Ashrafian H., Dwivedi G., Collinson P. O., Senior R., Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: implication for diagnosis of diastolic heart failure. European Journal of Heart Failure 2006 8 1 38 45 2-s2.0-29444460511 10.1016/j.ejheart.2005.05.008 (Pubitemid 43012099)
44. Hunt S. A., Abraham W. T., Chin M. H., Feldman A. M., Francis G. S., Ganiats T. G., Jessup M., Konstam M. A., Mancini D. M., Michl K., Oates J. A., Rahko P. S., Silver M. A., Stevenson L. W., Yancy C. W., American College of Cardiology Foundation, American Heart Association, 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. Journal of the American College of Cardiology 2009 53 15 e1 e90 2-s2.0-63849177462 10.1016/j.jacc.2008.11.013
45. Guglin M., Khan H., Pulmonary hypertension in heart failure. Journal of Cardiac Failure 2010 16 6 461 474 2-s2.0-77953610725 10.1016/j.cardfail.2010.01. 003
46. Redfield M. M., Rodeheffer R. J., Jacobsen S. J., Mahoney D. W., Bailey K. R., Burnett J. C. Jr., Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 2004 109 25 3176 3181 2-s2.0-4143128382
47. Groenning B. A., Raymond I., Hildebrandt P. R., Nilsson J. C., Baumann M., Pedersen F., Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004 90 3 297 303 2-s2.0-1342322743 (Pubitemid 38250725)
48. Vasan R. S., Benjamin E. J., Larson M. G., Leip E. P., Wang T. J., Wilson P. W. F., Levy D., Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. The Journal of the American Medical Association 2002 288 10 1252 1259 2-s2.0-0037063415 (Pubitemid 35001328)
49. Costello-Boerrigter L. C., Boerrigter G., Redfield M. M., Rodeheffer R. J., Urban L. H., Mahoney D. W., Jacobsen S. J., Heublein D. M., Burnett J. C. Jr., Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. Journal of the American College of Cardiology 2006 47 2 345 353 2-s2.0-30344446989 10.1016/j.jacc.2005.09.025 (Pubitemid 43063253)
50. Whalley G. A., Wright S. P., Pearl A., Gamble G. D., Walsh H. J., Richards M., Doughty R. N., Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community. European Heart Journal 2008 29 4 509 516 2-s2.0-39349116232 10.1093/eurheartj/ ehm647 (Pubitemid 351264193)
51. de Lemos J. A., McGuire D. K., Khera A., Das S. R., Murphy S. A., Omland T., Drazner M. H., Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas heart study. The American Heart Journal 2009 157 4 746 753 2-s2.0-62949168054 10.1016/j.ahj.2008.12.017
52. Lam C. S. P., Cheng S., Choong K., Larson M. G., Murabito J. M., Newton-Cheh C., Bhasin S., McCabe E. L., Miller K. K., Redfield M. M., Vasan R. S., Coviello A. D., Wang T. J., Influence of sex and hormone status on circulating natriuretic peptides. Journal of the American College of Cardiology 2011 58 6 618 626 2-s2.0-79960924613 10.1016/j.jacc.2011.03.042
53. Fox E. R., Musani S. K., Bidulescu A., Nagarajarao H. S., Samdarshi T. E., Gebreab S. Y., Sung J. H., Steffes M. W., Wang T. J., Taylor H. A., Vasan R. S., Relation of obesity to circulating B-type natriuretic peptide concentrations in blacks: the Jackson heart study. Circulation 2011 124 9 1021 1027 2-s2.0-80055078484 10.1161/CIRCULATIONAHA.110.991943
54. Redfield M. M., Rodeheffer R. J., Jacobsen S. J., Mahoney D. W., Bailey K. R., Burnett J. C. Jr., Plasma brain natriuretic peptide concentration: impact of age and gender. Journal of the American College of Cardiology 2002 40 5 976 982 2-s2.0-0037019567 10.1016/S0735-1097(02)02059-4 (Pubitemid 34994995)
55. Daniels L. B., Bhalla V., Clopton P., Hollander J. E., Guss D., McCullough P. A., Nowak R., Green G., Saltzberg M., Ellison S. R., Bhalla M. A., Jesse R., Maisel A., B-type natriuretic peptide (BNP) levels and ethnic disparities in perceived severity of heart failure. Results from the rapid emergency department heart failure outpatient trial (REDHOT) multicenter study of BNP levels and emergency department decision making in patients presenting with shortness of breath. Journal of Cardiac Failure 2006 12 4 281 285 2-s2.0-33646179066 10.1016/j.cardfail.2006.01.008
56. Perman S. M., Chang A. M., Hollander J. E., Gaieski D. F., Trzeciak S., Birkhahn R., Otero R., Osborn T. M., Moretti E., Nguyen H. B., Gunnerson K. J., Milzman D., Goyal M., Cairns C. B., Ngo L., Rivers E. P., Shapiro N. I., Relationship between B-type natriuretic peptide and adverse outcome in patients with clinical evidence of sepsis presenting to the emergency department. Academic Emergency Medicine 2011 18 2 219 222 2-s2.0-79951668615 10.1111/j.1553-2712.2010.00968.x
57. Feola M., Lombardo E., Taglieri C., Piccolo S., Vado A., Plasma BNP and renal failure as prognostic factors of mid-term clinical outcome in congestive heart failure patients. International Journal of Cardiology 2011 149 1 114 115 2-s2.0-79955942852 10.1016/j.ijcard.2011.01.047
58. Balik M., Jabor A., Otahal M., Waldauf P., Pavlisova M., Impact of acute renal failure on the relationship between N-Terminal pro-B-type natriuretic peptide and hemodynamic parameters. Blood Purification 2011 31 1-3 47 54 2-s2.0-78650041772 10.1159/000322259
59. Cruz D. N., Goh C. Y., Palazzuoli A., Slavin L., Calabrò A., Ronco C., Maisel A., Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes. Heart Failure Reviews 2011 16 6 545 551 2-s2.0-80052480869 10.1007/s10741-011-9231-9
60. Tigen K., Karaahmet T., Cevik C., Gurel E., Mutlu B., Basaran Y., Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function. The American Journal of the Medical Sciences 2009 337 2 109 115 2-s2.0-61849112744 10.1097/MAJ.0b013e31818128b5
61. Palazzuoli A., Silverberg D. S., Iovine F., Calabrò A., Campagna M. S., Gallotta M., Nuti R., Effects of β -erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. The American Heart Journal 2007 154 4 645.e9 645.e15 2-s2.0-34548767764 10.1016/j.ahj.2007.07.022 (Pubitemid 47429604)
62. van Kimmenade R. R. J., Pinto Y. M., Bayes-Genis A., Lainchbury J. G., Richards A. M., Januzzi J. L. Jr., Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. The American Journal of Cardiology 2006 98 3 386 390 2-s2.0-33745935642 10.1016/j.amjcard.2006.02.043 (Pubitemid 44062449)
63. Brenden C. K., Hollander J. E., Guss D., McCullough P. A., Nowak R., Green G., Saltzberg M., Ellison S. R., Bhalla M. A., Bhalla V., Clopton P., Jesse R., Maisel A. S., Gray zone BNP levels in heart failure patients in the emergency department: results from the rapid emergency department heart failure outpatient trial (REDHOT) multicenter study. The American Heart Journal 2006 151 5 1006 1011 2-s2.0-33646833633
64. Parrinello G., Torres D., Paterna S., Di Pasquale P., Licata G., Wet BNP, fluid and hemodynamic status at discharge in acute heart failure. International Journal of Cardiology 2010 145 2 335 336 2-s2.0-78650035853 10.1016/j.ijcard.2009.11.059